These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1365821)

  • 1. Management of renal disease and hypertension in insulin-dependent diabetes, with an emphasis on early nephropathy.
    Mogensen CE
    Curr Opin Nephrol Hypertens; 1992 Oct; 1(1):106-15. PubMed ID: 1365821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
    Mogensen CE
    J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention.
    Mogensen CE; Hansen KW; Nielsen S; Pedersen MM; Rehling M; Schmitz A
    Am J Kidney Dis; 1993 Jul; 22(1):174-87. PubMed ID: 8322781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus.
    Mogensen CE; Petersen MM; Hansen KW; Christensen CK
    J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of early nephropathy in diabetic patients.
    Mogensen CE
    Annu Rev Med; 1995; 46():79-93. PubMed ID: 7598486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension.
    Mogensen CE
    J Intern Med; 1994 Apr; 235(4):297-316. PubMed ID: 8151262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and microalbuminuria as predictors of diabetic nephropathy.
    Jones SL; Viberti GC
    Diabete Metab; 1989; 15(5 Pt 2):327-32. PubMed ID: 2612717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus.
    Parving HH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S19-24. PubMed ID: 1382160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic renal disease in type 1 diabetes: aetiology and prevention.
    Viberti GC
    Diabet Med; 1991; 8 Spec No():S38-42. PubMed ID: 1825955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the development of diabetic nephropathy and its progression.
    William J; Hogan D; Batlle D
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):202-11. PubMed ID: 15822056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
    Mogensen CE
    Diabetes; 1990 Jul; 39(7):761-7. PubMed ID: 2191882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotection in diabetes. With special reference to insulin-dependent patients.
    Mogensen CE
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2471-8. PubMed ID: 8571097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM.
    Mogensen CE; Hansen KW; Pedersen MM; Christensen CK
    Diabetes Care; 1991 Nov; 14 Suppl 4():13-26. PubMed ID: 1748053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus.
    Parving HH
    Diabetes Care; 1991 Mar; 14(3):260-9. PubMed ID: 2044441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.